Metadon 2care4 (Methadone Hydrochloride)

Methadone hydrochloride works by fully activating μ‑opioid receptors, which produces analgesia and suppresses withdrawal symptoms. It also blocks NMDA receptors, which can reduce the development of tolerance and may improve pain control in neuropathic conditions. The drug is metabolized mainly by liver enzymes CYP3A4 and CYP2B6.

The appropriate dose of Metadon 2care4 is individualized and determined by the prescribing clinician based on the patient’s medical condition, prior opioid exposure, and response to therapy. Dosage adjustments are made under medical supervision to achieve therapeutic goals while minimizing adverse effects.

Methadone hydrochloride is classified as Pregnancy Category C, indicating that risk to the fetus cannot be ruled out and the drug should only be used if the potential benefit justifies the potential risk. It is excreted in breast milk, so breastfeeding mothers should discuss risks and benefits with their healthcare provider.

To request Metadon 2care4, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Compared with shorter‑acting opioids, methadone provides a longer duration of action, which can reduce dosing frequency for chronic pain or maintenance therapy. Its NMDA antagonism may also lessen tolerance development. However, methadone requires careful cardiac monitoring due to QT‑prolongation risk, a consideration less prominent with many other opioids.

Metadon 2care4 should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablet appears discolored.

Metadon 2care4 is administered orally, typically as a tablet or liquid formulation, as directed by a qualified prescriber. The dose may be taken with or without food, but consistency with regard to meals can help reduce gastrointestinal side effects.

The most serious risks include respiratory depression, especially when combined with other central nervous system depressants, and cardiac arrhythmias due to QT‑interval prolongation. Patients should be monitored closely for signs of severe sedation, shallow breathing, or irregular heart rhythms, and medical attention should be sought immediately if these occur.

Metadon 2care4 should be avoided in individuals with known hypersensitivity to methadone, those with severe respiratory insufficiency, uncontrolled cardiac arrhythmias, or a history of QT prolongation. It is also contraindicated in patients currently taking monoamine oxidase inhibitors or who are in acute intoxication with alcohol or other CNS depressants.